dc.contributor.author | Castaneda Zegarra, Sergio Miguel | |
dc.contributor.author | Fernandez Berrocal, Marion Silvana | |
dc.contributor.author | Tkachev, Max | |
dc.contributor.author | Yao, Rouan | |
dc.contributor.author | Esnardo Upfold, Nikki Lyn | |
dc.contributor.author | Oksenych, Valentyn | |
dc.date.accessioned | 2021-01-22T13:28:50Z | |
dc.date.available | 2021-01-22T13:28:50Z | |
dc.date.issued | 2020-07-12 | |
dc.description.abstract | Non‐homologous end joining (NHEJ) is the main DNA repair mechanism for the repair of double‐strand breaks (DSBs) throughout the course of the cell cycle. DSBs are generated in developing B and T lymphocytes during V(D)J recombination to increase the repertoire of B and T cell receptors. DSBs are also generated during the class switch recombination (CSR) process in mature B lymphocytes, providing distinct effector functions of antibody heavy chain constant regions. Thus, NHEJ is important for both V(D)J recombination and CSR. NHEJ comprises core Ku70 and Ku80 subunits that form the Ku heterodimer, which binds DSBs and promotes the recruitment of accessory factors (e.g., DNA‐PKcs, Artemis, PAXX, MRI) and downstream core factors (XLF, Lig4 and XRCC4). In recent decades, new NHEJ proteins have been reported, increasing complexity of this molecular pathway. Numerous <i>in vivo</i> mouse models have been generated and characterized to identify the interplay of NHEJ factors and their role in development of adaptive immune system. This review summarizes the currently available mouse models lacking one or several NHEJ factors, with a particular focus on early B cell development. We also underline genetic interactions and redundancy in the NHEJ pathway in mice. | en_US |
dc.identifier.citation | Castaneda Zegarra, Fernandez Berrocal, Tkachev, Yao, Esnardo Upfold, Oksenych. Genetic interaction between the non‐homologous end joining factors during B and T lymphocyte development: in vivo mouse models. Scandinavian Journal of Immunology. 2020;92:e12936(4):1-9 | en_US |
dc.identifier.cristinID | FRIDAID 1819659 | |
dc.identifier.doi | 10.1111/sji.12936 | |
dc.identifier.issn | 0300-9475 | |
dc.identifier.issn | 1365-3083 | |
dc.identifier.uri | https://hdl.handle.net/10037/20396 | |
dc.language.iso | eng | en_US |
dc.publisher | Wiley | en_US |
dc.relation.journal | Scandinavian Journal of Immunology | |
dc.rights.accessRights | openAccess | en_US |
dc.rights.holder | Copyright 2020 The Author(s) | en_US |
dc.subject | VDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710 | en_US |
dc.subject | VDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710 | en_US |
dc.title | Genetic interaction between the non‐homologous end joining factors during B and T lymphocyte development: in vivo mouse models | en_US |
dc.type.version | publishedVersion | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |